Trial Profile
Effect of tolvaptan in pediatric congestive heart failure patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms J-SPECH
- 15 Apr 2015 New trial record